Considerations for using potential surrogate endpoints in cancer screening trials

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00015-9/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonc&_hsenc=p2ANqtz-8t6t9nWjyxeWvHEjwFORTZTuKlTQkfQ7VK-sLe6aZyJ8q5vSnJemSYIRFT-1B_DfhmvdpW4Usxtb2shUOhng2R0E5WVw&_hsmi=306819090&utm_content=306794605&utm_source=hs_email Curbing the climb in cancer incidence The Lancet Oncology https://www.thelancet.com/journals/lanonc/issue/vol25no5/PIIS1470-2045(24)X0005-4